IBM's CEO revealed disappointing Q2 2026 results, with revenue growth only 1% and a 7% drop in Infrastructure revenue, mainly due to problems with IBM Z mainframe performance. This announcement caused IBM shares to fall 25%, wiping out over $68 billion in market value. Hagens Berman law firm is investigating whether IBM misled investors about its strong start to the year and delayed disclosure of deal failures. Investors with losses or insider information are encouraged to contact the firm as the probe continues.
IBM has partnered with OpenAI to bring OpenAI's AI models and tools, including GPT-5.6 and Codex, to more enterprise customers through IBM's global consulting business. The deal involves joint marketing and development of industry-specific AI solutio...
IBM's recent quantum computing research shows quantum systems can outperform classical computers on specific problems, marking a technical milestone. However, CFOs should prioritize the economic impact, including costs of runtime, integration, and ta...
President Trump's executive order to separate the combined MMR vaccine into individual shots faces significant regulatory and manufacturing challenges, with FDA approval potentially taking up to 10 years. Merck and GSK, the only licensed producers of...
IBM announced a strategic partnership with OpenAI to integrate OpenAI's advanced models like GPT-5.6 into IBM Consulting's AI platform. This collaboration aims to help enterprises modernize legacy systems, automate workflows, and enhance cybersecurit...
Kyndryl Holdings, an IT infrastructure services provider spun off from IBM, has seen its stock rise nearly 12% over the past 30 days but recently dipped 3.77% in the last 10 days, possibly creating a buying opportunity. Analysts forecast a 12.85% ups...
